Maze Therapeutics grants director 18,000 stock options
Maze Therapeutics director Jonathan E. Lim received a grant of 18,000 stock options for common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Maze Therapeutics director Jonathan E. Lim received a grant of 18,000 stock options for common stock. The options have an exercise price of $23.58 per share and bring his reported option holdings to 18,000.
The award vests and becomes fully exercisable on the earlier of the company’s 2027 annual stockholders meeting or June 8, 2027, if he continues serving the company through that date. This is a compensation-related grant rather than an open-market purchase or sale.
Insider Trade Summary
Grant/Award: 18,000 shares
Grant/Award
1 txn
Insider
Lim Jonathan E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 18,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,000 contracts (Direct)
Footnotes (1)
- F1. The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.
Key Figures
Options granted: 18,000 options
Exercise price: $23.58 per share
Total options held after grant: 18,000 options
+2 more
5 metrics
Options granted
18,000 options
Stock Option (Right to Buy) grant to director Lim
Exercise price
$23.58 per share
Exercise price of granted stock options
Total options held after grant
18,000 options
Total derivative securities following transaction
Expiration date
June 7, 2036
Option expiration date
Underlying shares
18,000 shares
Common stock underlying granted options
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 23.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-07T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The option shall vest and be fully exercisable on the earlier of..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Maze Therapeutics (MAZE) report for Jonathan E. Lim?
Maze Therapeutics reported that director Jonathan E. Lim received a grant of 18,000 stock options. These options give him the right to buy common shares at a fixed exercise price as part of his director compensation, not through open-market trading.
How many Maze Therapeutics (MAZE) options did Jonathan E. Lim receive and at what price?
Jonathan E. Lim received 18,000 stock options with an exercise price of $23.58 per share. This means he can later buy Maze Therapeutics common stock at $23.58, regardless of the market price at exercise, once the options vest.
When do Jonathan E. Lim’s Maze Therapeutics (MAZE) stock options vest?
The options vest and become fully exercisable on the earlier of Maze Therapeutics’ 2027 annual stockholders meeting or June 8, 2027. Vesting is conditional on Lim’s continued service to the company through that vesting date, aligning the award with ongoing board service.
When do Jonathan E. Lim’s Maze Therapeutics (MAZE) stock options expire?
The stock options granted to Jonathan E. Lim expire on June 7, 2036. After this expiration date, any unexercised options become worthless, so he must wait for vesting but exercise before that 2036 expiration to benefit from the grant.
Are Jonathan E. Lim’s Maze Therapeutics (MAZE) options an open-market purchase or compensation grant?
The 18,000 Maze Therapeutics options are a compensation-related grant, not an open-market purchase. They were awarded at a $0.00 grant price with a $23.58 exercise price, consistent with equity awards directors receive for their board service at the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
